Lv11
74 积分 2026-01-22 加入
Updated Overall Survival and Exploratory Analysis From Randomized, Phase II EVAN Study of Erlotinib Versus Vinorelbine Plus Cisplatin Adjuvant Therapy in Stage IIIA Epidermal Growth Factor Receptor+ Non–Small-Cell Lung Cancer
13天前
已完结
Cross-ancestry genome-wide association meta-analyses of hippocampal and subfield volumes
14天前
已完结
A single-cell atlas of large B cell lymphomas reveals distinct malignant archetypes predictive of clinical outcomes
20天前
已完结
Dysregulated KMT2D mutant targeting immunogenic rewiring to overcome epigenetic entropy promotes follicular lymphomagenesis
21天前
已完结
Targeting the origins of multiple myeloma along hematopoietic stem cell lymphoid lineage differentiation
24天前
已完结
A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
1个月前
已完结
Lenalidomide Plus Rituximab for Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-Up and Subgroup Analyses From the Phase III AUGMENT Trial
1个月前
已完结
Treatment of relapsed and refractory follicular lymphoma: which treatment for which patient for which line of therapy?
1个月前
已完结
The future of follicular lymphoma management: strategies on the horizon
1个月前
已完结
皖公网安备34019202002308
